The Department of Defense (DoD) is offering the Ovarian Cancer Clinical Development Award to support the translation of promising preclinical findings into clinical products for ovarian cancer applications, including prevention, detection, diagnosis, treatment, or quality of life. This grant is for accelerating the clinical introduction of medical products and technologies that target ovarian cancer biology, with a strong expectation of near-term clinical impact. Proof of concept for the proposed product must already be established, and preclinical animal studies are not permitted. Eligible projects include small-scale clinical trials (Phase 0, Phase 1, Pilot), studies designed to enrich an ongoing clinical trial, or projects associated with ongoing or completed clinical trials. Applicants are required to provide relevant, supportive published or unpublished data.
Opportunity ID: 293665
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-OCRP-CDA |
| Funding Opportunity Title: | DoD Ovarian Cancer Clinical Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 06, 2017 |
| Last Updated Date: | Apr 24, 2018 |
| Original Closing Date for Applications: | Sep 06, 2017 |
| Current Closing Date for Applications: | Sep 06, 2017 |
| Archive Date: | Oct 06, 2017 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507
Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Action is modified to include Eligibility Statement for the Nested Early-Career Investigator option. | Apr 24, 2018 | |
| Apr 24, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-OCRP-CDA |
| Funding Opportunity Title: | DoD Ovarian Cancer Clinical Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 06, 2017 |
| Last Updated Date: | Apr 24, 2018 |
| Original Closing Date for Applications: | Sep 06, 2017 |
| Current Closing Date for Applications: | Sep 06, 2017 |
| Archive Date: | Oct 06, 2017 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507
Email:help@eBRAP.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-OCRP-CDA |
| Funding Opportunity Title: | DoD Ovarian Cancer Clinical Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 24, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 06, 2017 |
| Archive Date: | Oct 06, 2017 |
| Estimated Total Program Funding: | $3,840,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The OCRP Clinical Development Award is intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507
Email:help@eBRAP.org |
Related Documents
Folder 293665 Full Announcement-FY17 OCRP CDA -> OCRP_FY17_CDA_PA_GGv2.pdf
Folder 293665 Full Announcement-FY17 OCRP CDA -> Clinical Development Award Nested Early Career Investigator eligibility statement.pdf
Packages
| Agency Contact Information: | 301-682-5507 Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00232386 | May 06, 2017 | Sep 06, 2017 | View |
Package 1
Mandatory forms
293665 RR_SF424_2_0-2.0.pdf
293665 RR_Budget_1_4-1.4.pdf
293665 RR_KeyPersonExpanded_2_0-2.0.pdf
293665 PerformanceSite_2_0-2.0.pdf
293665 AttachmentForm_1_2-1.2.pdf
Optional forms
293665 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
